Hedge fund CEO gifts $15M for Alzheimer’s institute

Kathy Mahdoubi | | Health Imaging | Molecular Imaging

The chief executive officer of Park Avenue hedge fund Third Point, is set to donate $15 million to Mount Sinai Hospital and the Icahn School of Medicine in New York City for a new research institute devoted to studying Alzheimer’s disease.

The CEO, Daniel Loeb, will be dedicating the new research institute to his late father, Ronald M. Loeb, who suffered from the disease, according to this Wall Street Journal report.

 

Funding the Next Alzheimer’s Fight

Kathy Mahdoubi

Related Content

New radiotracer has 'incredible potential' to improve management of spinal cord injuries
Frontotemporal dementia often misdiagnosed due to misinterpretations of imaging
Endometriosis imaging agent impresses at clinical trials
Experts say one radiotracer outperforms all others when it comes to detecting prostate cancer
Radiotracers on FDA’s fast track exceed performance of already approved tau-detecting agent
PET scans unlock clues that could help prevent epilepsy induced by head injuries

Around the web

Radiology Business
Shift toward imaging outside the hospital could save billions

David A. Rosman, MD, MBA, deputy chief, radiology enterprise service, Mass General Brigham, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

Cardiovascular Business
Continuation of 99mTc-PYP shortage prompts need for alternative cardiac amyloidosis imaging

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.